|
1 Indications And Usage Monotherapy Fulvestrant Injection Is Indicated For The Treatment Of: • Hormone Receptor (hr)-Positive, Human Epidermal Growth Factor Receptor 2 (her2)-Negative Advanced Breast Cancer In Postmenopausal Women Not Previously Treated With Endocrine Therapy, Or • Hr-Positive Advanced Breast Cancer In Postmenopausal Women With Disease Progression Following Endocrine Therapy. Fulvestrant Injection Is An Estrogen Receptor Antagonist Indicated For The Treatment Of: • Hormone Receptor (hr)-Positive, Human Epidermal Growth Factor Receptor 2 (her2)-Negative Advanced Breast Cancer In Postmenopausal Women Not Previously Treated With Endocrine Therapy. ( 1 ) • Hr-Positive Advanced Breast Cancer In Postmenopausal Women With Disease Progression Following Endocrine Therapy. ( 1 )
|